Conley Chee

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Conley Chee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. President & CEO, Director Common Stock 0 $0 $2.09 Nov 18, 2024 Direct
Syros Pharmaceuticals, Inc. President & CEO, Director Restricted Stock Units 0 $0 $2.09 Oct 31, 2024 Direct

Insider Reports Filed by Conley Chee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Nov 18, 2024 1 -$26.9K 4 Nov 20, 2024 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2024 3 -$18.2K 4 Nov 4, 2024 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Sep 10, 2024 2 $161K 4 Sep 12, 2024 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2024 5 -$17.9K 4 Apr 2, 2024 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Dec 2, 2023 1 $0 4 Dec 5, 2023 President & CEO, Director
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2023 3 -$13.3K 4 Nov 2, 2023 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$1.7K 4 Apr 4, 2023 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 11, 2022 2 $0 4 Oct 11, 2022 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4/A Oct 11, 2022 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Sep 27, 2021 1 $0 4 Sep 28, 2021 Chief Commercial Officer
SYRS Syros Pharmaceuticals, Inc. Sep 27, 2021 0 $0 3 Sep 28, 2021 Chief Commercial Officer